# Albumin in Acute Ischemic Stroke Trial

> **NCT00235495** · PHASE3 · TERMINATED · sponsor: **University of Miami** · enrollment: 841 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **BIOLOGICAL:** Albumin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00235495
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 841 (ACTUAL)
- **Why stopped:** Recruitment halted by DSMB following interim analysis.
- **Last updated:** 2019-12-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235495, "Albumin in Acute Ischemic Stroke Trial". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00235495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*